Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AZTR
#4561
Azitra Inc
0.166
9
USD
-6.13%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-6.13%
Monthly Change
+1.40%
6 month change
+1.40%
Year Change
+1.40%
Previous Close
0.177
8
Open
0.166
5
Bid
0.166
9
Ask
0.169
9
Low
0.164
1
High
0.166
9
Volume
34
Markets
US Stock Market
Healthcare
AZTR
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2023
2024
2025
TTM
Key stats
Total common shares outstanding
144.17 K
2.25 M
16.19 M
—
Valuation ratios
Enterprise value
—
—
2.22 M
—
Price to earnings ratio
—
—
-0.12
—
Price to sales ratio
—
—
—
—
Price to cash flow ratio
—
—
-0.11
—
Price to book ratio
—
—
0.34
—
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
-2.21
-1.22
-2.18
-2.34
Return on equity %
-3.87
-1.57
-2.88
-3.79
Return on invested capital %
1 049.1
1 657.21
-1 795.31
-738.43
Gross margin %
100
100
—
—
Operating margin %
1 107.87
146.67 K
—
—
EBITDA margin %
—
—
—
—
Net margin %
-1 644.87
-119.57 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
1.58
3.8
2.83
8.32
Inventory turnover
—
—
—
—
Asset turnover
0.13
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
Long term debt to total equity ratio
0
—
—
—
Per share metrics
Operating cash flow per share
213.52
17.95
-2.3
2.7
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
51.82
8.02
0.42
2.81
Net current asset value per share
73.16
9.2
0.62
3.85
Tangible book value per share
77.97
9.59
0.71
4.11
Working capital per share
26.9
6.78
0.4
1.96
Book value per share
84.06
10.03
0.78
4.47
News
Azitra receives NYSE delisting warning over equity shortfall
Azitra receives approval for NYSE American compliance plan
Azitra announces $1.5 million private placement at premium to market
Azitra denies false report of $44 million registered direct offering
Azitra stock soars after positive preclinical data for ichthyosis treatment
Azitra reports positive preclinical data for ichthyosis treatment
Azitra receives NYSE American non-compliance notice
Azitra stock soars after first patient dosed in Phase 1/2 trial
Azitra doses first patient in phase 1/2 trial for cancer therapy rash
Upcoming Stock Splits This Week (August 18 to August 22) – Stay Invested - TipRanks.com
Azitra announces 1-for-6.66 reverse stock split effective August 21
Azitra shareholders approve doubling of authorized common stock